Clinical PresentationA 29-year-old primigravida weighing 80 kg presented to the labor room from home, at 37 weeks with a history of visual disturbances and headaches for one week. He also complained of epigastric pain and edema of the lower limbs. At the hospital, the patient had an episode of seizures that lasted approximately 30 seconds. Examination The care setting includes a labor and delivery unit. Furthermore, it has a side laboratory for accelerated laboratory measurements. The attending nurse was asked to measure the patient's blood pressure. This was done by placing the cuff at heart level and taking diastolic readings from the abolition of heart sounds. He was found to have a systolic blood pressure of 180 mmHg and a diastolic blood pressure of 110 mmHg. Laboratory tests revealed that he had 0.5 g of protein in his urine and that marked thrombocytopenia was present along with impaired liver function. A diagnosis of preeclampsia was made. Based on these measurements the patient was classified as having severe preeclampsia and as such the severe preeclampsia protocol was initiated. Other laboratory tests carried out confirmed the diagnosis. These included an elevated aspartate aminotransferase AST level and low platelet count. Multidisciplinary team approach The attending nurse transferred the patient to a spacious room within the labor ward. He then called the attending obstetrician and explained the situation at hand. He subsequently called the anesthetist and a doctor specializing in obstetrics and informed them, requesting their presence. An ICU observation chart was obtained and monitoring was initiated to ensure constant monitoring… half of paper… on tendon reflexes immediately after administration of the loading dose. Subsequently monitoring is carried out on an hourly basis. Additionally, respiratory rate was monitored hourly in addition to monitoring the patient's level of consciousness at the hourly rate and urine output. During the infusion process, urine output was observed to drop below 50 ml over a 2-hour period. The obstetric specialist was immediately called by the attending nurse. The specialist ordered the maintenance infusion to be stopped. The anesthetist was notified and a blood sample was taken to determine the amount of magnesium in the blood vapor. 1 g of calcium gluconate was administered intravenously over a period of 3 minutes to counteract the toxic effects of magnesium sulfate on the heart. The patient stabilized and the respiratory rate returned to normal.